Literature DB >> 7789479

Variability of FVC and FEV1 due to technician, team, device and subject in an eight centre study: three quality control studies in SAPALDIA. Swiss Study on Air Pollution and Lung Disease in Adults.

N Künzli1, U Ackermann-Liebrich, R Keller, A P Perruchoud, C Schindler.   

Abstract

Lung function testing of a random population sample in the eight SAPALDIA (Swiss study on air pollution and lung diseases in adults) centres had to be performed simultaneously, within one year, by eight teams and 23 technicians. We conducted quality control studies to test for technician, team and device related systematic measurement errors. To assess technician effects, each centre conducted a study involving 12-19 subjects. Two studies with 13 participants each addressed team and device effects. In all studies, volunteers repeatedly performed spirometry with different technicians or devices. Effects due to technician, team or device were estimated (analysis of variance). Neither "technician" within any of eight teams nor "team" accounted for significant differences of forced vital capacity (FVC) or forced expiratory volume in one second (FEV1). The Device Effect Study revealed 10% lower FVC values for device No. 1 due to a technical problem occurring during the test day but not in the main SAPALDIA study. Further investigations revealed potential hardware and software sources of error which are not recognizable by trained technicians. These studies gave no evidence for systematic errors due to technician, team or device during the main SAPALDIA study. However, they revealed potential sources of error in modern devices, which function as "black boxes". Manufacturers should improve spirometry software to further enhance the technicians' attempts at accurate assessment.

Entities:  

Mesh:

Year:  1995        PMID: 7789479     DOI: 10.1183/09031936.95.08030371

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  16 in total

1.  Quantitative computed tomography detects interstitial lung diseases proven by biopsy.

Authors:  Alarico Ariani; Andrea Imperatori; Massimo Castiglioni; Elisa Daffrè; Marina Aiello; Giuseppina Bertorelli; Alfredo Chetta; Lorenzo Dominioni; Nicola Rotolo
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

2.  Lung function decline over 25 years of follow-up among black and white adults in the ARIC study cohort.

Authors:  Maria C Mirabelli; John S Preisser; Laura R Loehr; Sunil K Agarwal; R Graham Barr; David J Couper; John L Hankinson; Noorie Hyun; Aaron R Folsom; Stephanie J London
Journal:  Respir Med       Date:  2016-02-11       Impact factor: 3.415

3.  Lung function in healthy never smoking adults: reference values and lower limits of normal of a Swiss population.

Authors:  O Brändli; C Schindler; N Künzli; R Keller; A P Perruchoud
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

4.  Calibrating the calibrators.

Authors:  P S Burge
Journal:  Thorax       Date:  1996-10       Impact factor: 9.139

5.  Association of environmental tobacco smoke at work and forced expiratory lung function among never smoking asthmatics and non-asthmatics. The SAPALDIA-Team. Swiss Study on Air Pollution and Lung Disease in Adults.

Authors:  N Künzli; J Schwartz; E Z Stutz; U Ackermann-Liebrich; P Leuenberger
Journal:  Soz Praventivmed       Date:  2000

Review 6.  Spirometric indices of early airflow impairment in individuals at risk of developing COPD: Spirometry beyond FEV1/FVC.

Authors:  Daniel Hoesterey; Nilakash Das; Wim Janssens; Russell G Buhr; Fernando J Martinez; Christopher B Cooper; Donald P Tashkin; Igor Barjaktarevic
Journal:  Respir Med       Date:  2019-08-09       Impact factor: 3.415

7.  Genome-wide association study of lung function decline in adults with and without asthma.

Authors:  Medea Imboden; Emmanuelle Bouzigon; Ivan Curjuric; Adaikalavan Ramasamy; Ashish Kumar; Dana B Hancock; Jemma B Wilk; Judith M Vonk; Gian A Thun; Valerie Siroux; Rachel Nadif; Florent Monier; Juan R Gonzalez; Matthias Wjst; Joachim Heinrich; Laura R Loehr; Nora Franceschini; Kari E North; Janine Altmüller; Gerard H Koppelman; Stefano Guerra; Florian Kronenberg; Mark Lathrop; Miriam F Moffatt; George T O'Connor; David P Strachan; Dirkje S Postma; Stephanie J London; Christian Schindler; Manolis Kogevinas; Francine Kauffmann; Debbie L Jarvis; Florence Demenais; Nicole M Probst-Hensch
Journal:  J Allergy Clin Immunol       Date:  2012-03-16       Impact factor: 10.793

8.  Decreased PM10 exposure attenuates age-related lung function decline: genetic variants in p53, p21, and CCND1 modify this effect.

Authors:  Medea Imboden; Joel Schwartz; Christian Schindler; Ivan Curjuric; Wolfgang Berger; Sally L J Liu; Erich W Russi; Ursula Ackermann-Liebrich; Thierry Rochat; Nicole M Probst-Hensch
Journal:  Environ Health Perspect       Date:  2009-05-26       Impact factor: 9.031

9.  Causal Effects of Body Mass Index on Airflow Obstruction and Forced Mid-Expiratory Flow: A Mendelian Randomization Study Taking Interactions and Age-Specific Instruments Into Consideration Toward a Life Course Perspective.

Authors:  Nicole Probst-Hensch; Ayoung Jeong; Daiana Stolz; Marco Pons; Paola M Soccal; Robert Bettschart; Deborah Jarvis; John W Holloway; Florian Kronenberg; Medea Imboden; Christian Schindler; Gianfranco F Lovison
Journal:  Front Public Health       Date:  2021-05-11

10.  Different genes interact with particulate matter and tobacco smoke exposure in affecting lung function decline in the general population.

Authors:  Ivan Curjuric; Medea Imboden; Rachel Nadif; Ashish Kumar; Christian Schindler; Margot Haun; Florian Kronenberg; Nino Künzli; Harish Phuleria; Dirkje S Postma; Erich W Russi; Thierry Rochat; Florence Demenais; Nicole M Probst-Hensch
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.